Our Portfolio

The Feinstein Institute for Medical Research

Yousef Al-Abed | NY, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $75,000 Funding Amount
  • 9/1/07 — 5/29/09 Project Duration
  • Drug Discovery Program
  • In Vivo Efficacy Therapeutic Stage
  • Closed Status

The Feinstein Institute for Medical Research

Yousef Al-Abed | NY, United States

CNI-1493 inhibits Abeta production and prevents plaque formation in an animal model of Alzheimer's Disease

GET IN TOUCH